2016 Annual Meeting – Pre Conference Workshop
Nucleic Acid Therapeutics Development 101
……………
Manufacturing Oligonucleotides from Bench to Bed
Marc M. LeMaitre, PhD, M_L Consult
Aptamers and SELEX: The Past, the Present and the Future
Paloma Giangrande, PhD, University of Iowa
Addressing Delivery Hurdles in the Translation of Oligonucleotide Therapeutics
Paul Burke, PhD, Burke Bioventures
Non Clinical Strategies for Oligonucleotide Development Programs
Jennifer Lockridge, PhD, Dicerma Pharmaceuticals
Q&A
Jennifer Lockridge, PhD Paloma Giagrande, PhD Paul Burke, PhD Marc M. Lemaitre, PhD
2016 Annual Meeting Welcome
……………
12 Annual Meeting of the Oligonucleotide Therapeutic Society
OTS President, Brett Monia, PhD, Ionis Pharmaceuticals
2016 Annual Meeting Keynote
……………
Noncoding RNA: Large, Small and Viral
Joan A. Steitz, PhD, Yale University, Howard Hughes Medical Institute
2016 Annual Meeting Award Winner Presentations
……………
Young Investigator Award
Preclinical Development of Tricyclo-DNA Antisense Oligonucleotides for the Treatment of Neuromuscular Diseases
Aurélie Goyenvalle, PhD, Université Saint Quentin en Yvelines
Paper of the Year
Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides
Victor Serebrov, PhD, RNA Therapeutics Institute, Mass Medical Center
……………
The Present and Future of Antisense Technology
Stanley T. Crooke, MD, PhD, Ionis Pharmaceuticals
“Aerial & Building Footage © 2016, courtesy City of Carlsbad”